Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015

BACKGROUND: Artemisinin-based combination therapy is the first-line anti-malarial treatment for uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of polymorphisms in the pfk13 gene, associated with artemisinin resistance, and pfmdr1, associated with lumefantrine resist...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Malar J
Main Authors: Ljolje, Dragan, Dimbu, Pedro Rafael, Kelley, Julia, Goldman, Ira, Nace, Douglas, Macaia, Aleixo, Halsey, Eric S., Ringwald, Pascal, Fortes, Filomeno, Udhayakumar, Venkatachalam, Talundzic, Eldin, Lucchi, Naomi W., Plucinski, Mateusz M.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5819161/
https://ncbi.nlm.nih.gov/pubmed/29458380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-018-2233-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados